Para-aortic lymphadenectomy for primary fallopian tube cancer

Int J Gynaecol Obstet. 2011 Jan;112(1):18-20. doi: 10.1016/j.ijgo.2010.07.025.

Abstract

Objective: To investigate the topography of lymph node spread and the need for para-aortic lymphadenectomy in primary fallopian tube cancer (PFTC).

Methods: Twenty-six women were diagnosed with PFTC at Cheil General Hospital and Women's Healthcare Center, Seoul, Korea, between March 1992 and November 2009. Of the 26 patients, we retrospectively analyzed 15 patients who underwent complete staging surgery, including bilateral pelvic and para-aortic lymphadenectomy.

Results: The median follow-up period was 57.9 months (range, 3-185 months) and the 5-year survival rate was 86.3%. Five (33.3%) patients were diagnosed with FIGO stage I, 1 (6.7%) with stage II, and 9 (60%) with stage III cancer. The median number of lymph nodes removed was 53.8 (range, 18-106 nodes). Four (26.7%) patients had nodal involvement: 2 patients with para-aortic lymph node involvement and 2 patients with both pelvic and para-aortic lymph node involvement. None of the patients was positive for pelvic lymph nodes alone.

Conclusion: A comprehensive para-aortic lymphadenectomy was necessary for accurate staging in PFTC.

MeSH terms

  • Adult
  • Aged
  • Fallopian Tube Neoplasms / pathology*
  • Female
  • Follow-Up Studies
  • Humans
  • Lymph Node Excision / methods*
  • Lymphatic Metastasis
  • Middle Aged
  • Neoplasm Staging / methods
  • Republic of Korea
  • Retrospective Studies
  • Survival Rate